The 20 Best Teratoma of the Mediastinum Doctors Near Me in Baltimore, MD

William Houck is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Houck is rated as an Advanced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Richter Syndrome. Dr. Houck is board certified in American Board Of Internal Medicine.

Dr. Noah Hahn is a medical oncologist in the Baltimore area, caring for patients with bladder cancer. He serves as the deputy director of the Greenberg Bladder Cancer Institute at the Johns Hopkins School of Medicine. Dr. Hahn earned his M.D. from Indiana University School of Medicine. He completed his residency in internal medicine at Duke University School of Medicine and performed a fellowship in medical oncology at Indiana University School of Medicine. Dr. Hahn joined the Johns Hopkins faculty in 2014. Prior to joining Johns Hopkins, Dr. Hahn was the director of the Genitourinary Medical Oncology Program at Indiana University and chief scientific officer for the Hoosier Oncology Group, a cancer research organization that evaluates innovative and promising approaches to cancer treatment. He is currently conducting clinical trials to test new therapies for bladder cancer, including those for early stage bladder cancer. Dr. Hahn is a member of the Bladder Cancer Task Force for the National Cancer Institute’s Genitourinary Cancer Steering Committee and is chair of the Bladder Cancer Subcommittee of the Eastern Cooperative Oncology Group. Dr. Hahn is rated as an Advanced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Nephrectomy.

Eric Raabe, M.D., Ph.D., is an associate professor of oncology and pathology at Johns Hopkins School of Medicine. Dr. Raabe majored in neural science at Brown University and received his M.D. and Ph.D. from the University of Cincinnati College of Medicine. He completed his pediatric internship and residency at Children’s Hospital of Philadelphia. After spending a year working in Africa as part of the Baylor International Pediatric AIDS Initiative, Dr. Raabe joined Johns Hopkins as a pediatric oncology fellow. Working in the laboratory of Charles Eberhart in Neuropathology, Dr. Raabe established a neural stem cell system to create genetically accurate models of pediatric brain tumors. In collaboration with patients and families, he has also developed multiple pediatric brain tumor cell lines that are some of the key models used for pre-clinical testing. Dr. Raabe sees patients in the pediatric oncology outpatient clinic at Johns Hopkins, with a focus on pediatric brain tumors. Dr. Raabe is also the point person in oncology for retinoblastoma care. He continues his research in the new Smith Building of the Wilmer Eye Institute in the Neuropathology Division, in collaboration with Charles Eberhart. Dr. Raabe is rated as an Advanced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Glioma, and Pediatric Low-Grade Glioma (pLGG). Dr. Raabe is board certified in American Board Of Pediatrics.

Dr. Koldobskiy is an Assistant Professor of Pediatric Oncology and Pediatric Neuro-Oncology at the Sidney Kimmel Comprehensive Cancer Center. He received his B.S. and M.S. from Yale University and M.D./Ph.D. in the Medical Scientist Training Program at Johns Hopkins, conducting his thesis research with Dr. Solomon Snyder in Pharmacology and Molecular Sciences. He completed his Pediatrics residency training at Johns Hopkins and his Pediatric Hematology and Oncology fellowship training in the joint Johns Hopkins/National Institutes of Health program. He studies epigenetic variability in childhood cancer. Dr. Koldobskiy is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. His clinical expertise encompasses Leukemia, Glioma, Acute Lymphoblastic Leukemia (ALL), and Teratoma of the Mediastinum. Dr. Koldobskiy is board certified in American Board Of Pediatrics.

Dr. Jean Hoffman-Censits is a genitourinary cancer specialist in Baltimore, caring for patients with urothelial cancers of the bladder and upper tract. She serves as co-leader of the Women’s Bladder Cancer Program in the Greenberg Bladder Cancer Institute at the Johns Hopkins University School of Medicine. Dr. Hoffman-Censits received her undergraduate degree in neuroscience from Trinity College. She earned her M.D. degree from the Sidney Kimmel Medical College of Thomas Jefferson University. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in hematology and oncology at Temple University Medical Center. She joined the Johns Hopkins faculty in 2018. Dr. Hoffman-Censits's research interests focus on urothelial cancers. Her clinical research has helped identify urothelial cancer sub-types and establish new treatments for bladder and upper tract urothelial cancers. She is a member of the American Medical Association, the American Society of Clinical Oncology, the American Urological Association and the Society for Immunotherapy of Cancer. Dr. Hoffman is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Bladder Reconstruction, and Nephrectomy. Dr. Hoffman is board certified in American Board Of Internal Medicine.

My clinical and research interests focus on disorders caused by telomere dysfunction. Our goal is to define approaches to surveillance, diagnosis and treatment for patients with telomere-mediated disease. Human syndromes associated with telomere shortening were first identified in the context of dyskeratosis congenita, a premature aging syndrome that predisposes to cancer. Dyskeratosis congenita patients and patients with telomere-mediated syndromes have an increased risk for developing certain malignancies which include myelodysplastic syndromes, myeloid leukemia and squamous cell carcinomas of the upper aerodigestive tract. The Telomere Clinic at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins provides multi-disciplinary care to patients who are suspected to have or who carry the diagnosis of telomere-related disorders. These disorders include individuals with cancer, bone marrow failure/aplastic anemia, lung disease including idiopathic pulmonary fibrosis and liver cirrhosis, among others. Our clinic brings together geneticists, genetic counselors, and we work closely with expert physicians in adult and pediatric hematology, bone marrow transplant, pulmonary medicine, lung transplant medicine, hepatology, and otolaryngology. Together, our team has established expertise in the management of these disorders and is at the forefront of leading the effort to individualize care for affected patients and their families. My group also has ongoing research efforts which include a long-term study to understand the genetics and spectrum of telomere disorders through a Registry which has been based at Johns Hopkins since 2005. Dr. Armanios is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Primary T Cell Immunodeficiency, Emphysema, and Ataxia-Telangiectasia. Dr. Armanios is board certified in American Board Of Internal Medicine.

Dr. Zambidis is Associate Professor of Oncology and Pediatrics at the Johns Hopkins University School of Medicine, and a member of the Johns Hopkins Kimmel Cancer Center. Dr. Zambidis’ clinical expertise is in the treatment of disorders of the immune system, histiocytic disorders, hematologic malignancies, blood and bone marrow transplantation (BMT), and regenerative medicine. His research interest focuses on advancing our understanding of pluripotent stem cells– the ‘master’ stem cells that can generate any new cell or tissue that the body needs to repair itself. Dr. Zambidis earned his M.D./Ph.D. in the Medical Scientist Training Program at the University of Rochester, Rochester, N.Y. He completed his Pediatrics Residency in the Department of Pediatrics, Washington University, St. Louis, Missouri, and his clinical/research fellowships in Pediatric Hematology/Oncology at the Johns Hopkins Hospital and the National Cancer Institute at the NIH. Dr. Zambidis has been interested in the biology of stem cells since he came to Johns Hopkins, in 2001. As a Pediatric Hematology/Oncology fellow, he was one of the very first Hopkins investigators to work with human embryonic stem cells (hESCs), beginning shortly after they were made available to the biomedical research community, in 2002. Dr. Zambidis was awarded the first NIH K08 Clinician-Scientist Training Award specifically investigating the therapeutic potential of human pluripotent stem cells (2004). After joining the Hopkins faculty, in 2005, he developed an experimental model of the early formation process of human blood and blood vessels using human pluripotent stem cells. The Zambidis laboratory at the Johns Hopkins Institute for Cell Engineering focuses on understanding the developmental biology of human hemato-vascular and human pluripotent stem cells. More recently, his group completed studies on highly efficient methods for generating nonintegrated, human induced pluripotent stem cell (hiPSC) lines from myeloid progenitors. His group has developed novel hiPSC-based vascular therapies for retinopathies, and more recently derived a new class of human pluripotent stem cells in a naïve ground state with new functionalities with even greater potency and stronger regenerative capacities. As a BMT physician-scientist, his long-term goal is to use hESC, hiPSC, and related pluripotent stem cell technologies to not only treat severe degenerative diseases, but also to elucidate the biological nature of cancer and aging. Dr. Zambidis is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. His clinical expertise encompasses Gaucher Disease, Reticulohistiocytoma, Rosai-Dorfman Disease, and Lymphofollicular Hyperplasia. Dr. Zambidis is board certified in American Board Of Pediatrics.

Nirmish Singla is an Oncologist practicing medicine in Lutherville, Maryland. Dr. Singla is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Singla is board certified in American Board Of Urology.

Arif Hussain is an Internal Medicine provider practicing medicine in Baltimore, Maryland. Dr. Hussain is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Prostate Cancer, and Familial Prostate Cancer.

Sonia Franco is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Franco is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Ataxia-Telangiectasia, Teratoma of the Mediastinum, and Immune Thrombocytopenic Purpura (ITP).

David Riseberg is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Riseberg is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer.

Heather Mannuel is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Mannuel is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Prostate Cancer, and Renal Cell Carcinoma (RCC).

Brad Lerner is a Urologist practicing medicine in Baltimore, Maryland. Dr. Lerner is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Prostatectomy.

Enser Cole is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Cole is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC).

Marvin Feldman is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Feldman is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Familial Colorectal Cancer, and Angiosarcoma.

Mahsa Mohebtash is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Mohebtash is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Syed Nasir is an Oncologist practicing medicine in Towson, Maryland. Dr. Nasir is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 85 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast. Dr. Nasir is currently accepting new patients.

Alice Barr is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Barr is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. Her clinical expertise encompasses Teratoma of the Mediastinum.

Kannan Manickam is a Urologist practicing medicine in Rosedale, Maryland. Dr. Manickam is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Urinary Incontinence, UPJ Obstruction, Enlarged Prostate (BPH), Urinary Tract Infection in Children, and Ureteroscopy.

Kevin Chen is a Hematologist practicing medicine in Baltimore, Maryland. He has been practicing medicine for over 18 years. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).